Clinical trial
Fibrinogen Replacement to Prevent Intracranial Haemorrhage in Ischemic Stroke Patients After Thrombolysis: a Pilot Probe Randomized Controlled Trial (FibER)
NCT05300672 is registered in ClinicalTrials.gov with Azienda Usl di Bologna as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Fibrinogen Replacement to Prevent Intracranial Haemorrhage in Ischemic Stroke Patients After Thrombolysis: a Pilot Probe Randomized Controlled Trial (FibER)
- Lead sponsor
- Azienda Usl di Bologna
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- February 8, 2022
- Completion date
- May 27, 2025
- Enrollment
- 207 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.